Moderna announces that it will supply 12 million doses of its bivalent COVID-19 vaccine aimed at targeting the Omicron variant
Moderna announces that it will supply 12 million doses of its bivalent COVID-19 vaccine aimed at targeting the Omicron variant.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthModerna announces that it will supply 12 million doses of its bivalent COVID-19 vaccine aimed at targeting the Omicron variant
View Premium plansBrowse free archive reportsModerna announces that it will supply 12 million doses of its bivalent COVID-19 vaccine aimed at targeting the Omicron variant.